drugset / Trial / NCT04585321

Comparative Bioavailability and Local Tolerability of Two Topical Diclofenac Plasters Applied Once and Twice a Day

NCT04585321

Phase 1 Completed 52 enrolled Fidia Farmaceutici s.p.a.
RandomizedCrossoverOpen-labelOther

Summary

Study Objectives Primary To evaluate the average bioequivalence in healthy volunteers between medicinal product of Diclofenac Sodium 140mg Medicated Plaster EQI7 in comparison to the reference medicinal product Flector®, applied once and twice a day. Secondary To evaluate pharmacokinetic profile on Day 1, adhesivity, local tolerability and safety of medicinal product Diclofenac Sodium 140mg Medicated Plaster EQI7 in healthy volunteers in comparison to the reference medicinal product Flector®, applied once and twice a day.

Timeline

Start
2017-11-28
Primary completion
2018-05-17
Completion
2018-05-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 140 mg Topical

Indications

No indication recorded.